Literature DB >> 7462236

Differential uptake of D-galactosyl- and D-glucosyl-neoglycoproteins by isolated rat hepatocytes.

K Kawaguchi, M Kuhlenschmidt, S Roseman, Y C Lee.   

Abstract

Bovine serum albumin was modified with 2-imino-2-methoxyethyl 1-thioglycopyranosides of galactose and glucose (Gal-AI-BSA, Glc-AI-BSA, respectively). Both types of neoglycoproteins were taken up by isolated rat hepatocytes. Gal-AI-BSA and Glc-AI-BSA inhibited the uptake of each other, and also inhibited the uptake of asialo-orosomucoid as expected from the results obtained with rabbit liver membranes (Stowell, C. P., and Lee, Y. C. (1978) J. Biol. Chem. 253, 6107-6110). Gal-neoglycoproteins of bovine serum albumin containing other linking groups between the galactose moiety and protein were found to be as effective in inhibition of the uptake of asialo-orosomucoid as Gal-AI-BSA, indicating that the method of carbohydrate attachment had little influence on endocytosis of galactose-terminated neoglycoproteins. In contrast, comparable Glc-neoglycoproteins (other than Glc-AI-BSA) were weak inhibitors. It thus appears that the positively charged amidino group present in Glc-AI-BSA contributes to the uptake of this neoglycoprotein by rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462236

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Endogenous and exogenous domain markers of the rat hepatocyte plasma membrane.

Authors:  J R Bartles; L T Braiterman; A L Hubbard
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

2.  Preparation and isolation of neoglycoconjugates using biotin-streptavidin complexes.

Authors:  B Kuberan; N S Gunay; J S Dordick; R J Linhardt
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

3.  Carbohydrate-dependent binding of human myeloid leukemia cell lines to neoglycoenzymes, matrix-immobilized neoglycoproteins, and bone marrow stromal cell layers.

Authors:  S Gabius; R Wawotzny; U Martin; S Wilholm; H J Gabius
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.